Bank of America’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-54,523
| Closed | -$318K | – | 8790 |
|
|
2025
Q1 | $318K | Sell |
54,523
-81,719
| -60% | -$431K | ﹤0.01% | 5912 |
|
|
2024
Q4 | $507K | Sell |
136,242
-141,896
| -51% | -$655K | ﹤0.01% | 5527 |
|
|
2024
Q3 | $1.55M | Sell |
278,138
-162,290
| -37% | -$1.14M | ﹤0.01% | 4751 |
|
|
2024
Q2 | $3.71M | Buy |
440,428
+105,781
| +32% | +$1.13M | ﹤0.01% | 3895 |
|
|
2024
Q1 | $4.83M | Buy |
334,647
+54,792
| +20% | +$906K | ﹤0.01% | 3643 |
|
|
2023
Q4 | $6.02M | Buy |
279,855
+85,698
| +44% | +$1.53M | ﹤0.01% | 3391 |
|
|
2023
Q3 | $3.73M | Buy |
194,157
+23,966
| +14% | +$511K | ﹤0.01% | 3672 |
|
|
2023
Q2 | $4.33M | Sell |
170,191
-17,649
| -9% | -$510K | ﹤0.01% | 3547 |
|
|
2023
Q1 | $6.79M | Sell |
187,840
-198,429
| -51% | -$6.97M | ﹤0.01% | 3219 |
|
|
2022
Q4 | $15.3M | Buy |
386,269
+253,787
| +192% | +$10.6M | ﹤0.01% | 2255 |
|
|
2022
Q3 | $6.17M | Sell |
132,482
-55,013
| -29% | -$2.55M | ﹤0.01% | 3111 |
|
|
2022
Q2 | $8.22M | Buy |
187,495
+18,581
| +11% | +$1.02M | ﹤0.01% | 2884 |
|
|
2022
Q1 | $12.2M | Buy |
168,914
+45,933
| +37% | +$3.31M | ﹤0.01% | 2663 |
|
|
2021
Q4 | $9.97M | Sell |
122,981
-28,862
| -19% | -$2.89M | ﹤0.01% | 2938 |
|
|
2021
Q3 | $17.7M | Sell |
151,843
-15,290
| -9% | -$2M | ﹤0.01% | 2286 |
|
|
2021
Q2 | $27.7M | Sell |
167,133
-166,826
| -50% | -$26M | ﹤0.01% | 1842 |
|
|
2021
Q1 | $46.6M | Buy |
333,959
+125,919
| +61% | +$20.5M | 0.01% | 1348 |
|
|
2020
Q4 | $36M | Sell |
208,040
-10,691
| -5% | -$1.73M | ﹤0.01% | 1407 |
|
|
2020
Q3 | $30.5M | Sell |
218,731
-29,070
| -12% | -$3.88M | ﹤0.01% | 1385 |
|
|
2020
Q2 | $29.6M | Buy |
247,801
+65,088
| +36% | +$7.72M | ﹤0.01% | 1340 |
|
|
2020
Q1 | $18.3M | Buy |
182,713
+50,245
| +38% | +$6.04M | ﹤0.01% | 1581 |
|
|
2019
Q4 | $15.6M | Sell |
132,468
-20,729
| -14% | -$2.05M | ﹤0.01% | 2123 |
|
|
2019
Q3 | $13.2M | Buy |
153,197
+409
| +0.3% | +$30.9K | ﹤0.01% | 2225 |
|
|
2019
Q2 | $9.9M | Buy |
152,788
+21,248
| +16% | +$1.32M | ﹤0.01% | 2567 |
|
|
2019
Q1 | $8.22M | Sell |
131,540
-764,176
| -85% | -$35.9M | ﹤0.01% | 2685 |
|
|
2018
Q4 | $34.8M | Buy |
895,716
+696,721
| +350% | +$31M | 0.01% | 1257 |
|
|
2018
Q3 | $11.3M | Sell |
198,995
-42,851
| -18% | -$2.68M | ﹤0.01% | 2369 |
|
|
2018
Q2 | $19.3M | Sell |
241,846
-18,199
| -7% | -$1.51M | ﹤0.01% | 1838 |
|
|
2018
Q1 | $22.5M | Sell |
260,045
-77,529
| -23% | -$6.26M | ﹤0.01% | 1672 |
|
|
2017
Q4 | $23.3M | Buy |
337,574
+102,904
| +44% | +$8.23M | ﹤0.01% | 1683 |
|
|
2017
Q3 | $21.3M | Buy |
234,670
+93,175
| +66% | +$7.98M | ﹤0.01% | 1817 |
|
|
2017
Q2 | $10.5M | Buy |
141,495
+950
| +0.7% | +$76.1K | ﹤0.01% | 2318 |
|
|
2017
Q1 | $13.2M | Sell |
140,545
-36
| -0% | -$3.26K | ﹤0.01% | 2134 |
|
|
2016
Q4 | $10.2M | Buy |
140,581
+39,227
| +39% | +$3.36M | ﹤0.01% | 2298 |
|
|
2016
Q3 | $10.6M | Buy |
101,354
+67,436
| +199% | +$6.09M | ﹤0.01% | 2191 |
|
|
2016
Q2 | $2.5M | Buy |
33,918
+29,718
| +708% | +$2.02M | ﹤0.01% | 3440 |
|
|
2016
Q1 | $236K | Buy |
4,200
+721
| +21% | +$42.5K | ﹤0.01% | 5052 |
|
|
2015
Q4 | $235K | Buy |
3,479
+3,353
| +2,661% | +$180K | ﹤0.01% | 5283 |
|
|
2015
Q3 | $6K | Sell |
126
-1,893
| -94% | -$91.7K | ﹤0.01% | 6717 |
|
|
2015
Q2 | $109K | Buy |
2,019
+1,992
| +7,378% | +$101K | ﹤0.01% | 5548 |
|
|
2015
Q1 | $1K | Buy |
+27
| New | +$1.17K | ﹤0.01% | 6866 |
|
Other funds holding NVRO
Bank of America's NVRO Position: Q2 2025 in Review
Bank of America sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 54,523 shares — an estimated $318K sold.
Bank of America first reported a position in NVRO in Q1 2015 and held it in 41 quarters. The position peaked at $46.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Bank of America reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 54,523 NEVRO CORP. shares in Q2 2025, an estimated $318K.
- Bank of America first reported a position in NEVRO CORP. in Q1 2015 and held it in 41 quarters.
- Bank of America's NEVRO CORP. position peaked at $46.6M in Q1 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.